|
|
Volumn 33, Issue 1-2, 2001, Pages 1353-1354
|
|
Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: Interim report of a prospective randomized trial
a
a
b
b
c
c
a
a
c
b
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN A;
INTERFERON;
RIBAVIRIN;
THYMOCYTE ANTIBODY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FOLLOW UP;
GRAFT REJECTION;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT INFECTION;
ADRENAL CORTEX HORMONES;
ANTIVIRAL AGENTS;
DRUG ADMINISTRATION SCHEDULE;
FOLLOW-UP STUDIES;
HEPATITIS C;
HUMANS;
INTERFERONS;
LIVER;
LIVER TRANSPLANTATION;
POSTOPERATIVE COMPLICATIONS;
PROSPECTIVE STUDIES;
RECURRENCE;
RIBAVIRIN;
|
|
EID: 0035082405
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02507-0 Document Type: Article |
|
Times cited : (22)
|
|
References (5)
|
